TRIM21 and systemic lupus erythematosus: The passive transfer of anti-Ro/SSA autoantibodies from an SLE-affected mother to her offspring is known to increase several clinical conditions, such as neonatal lupus rash and hepatic and central nervous system involvement (5, 6).